Another oral medication for people with type 1 diabetes recently struck out with the FDA, but approvals in Europe and Japan lead us to believe that the game isn’t yet over here in the states.
read more →
Drs. Jeremy Pettus and Schafer Boeder led our Type 1 Spotlight Series in San Diego recently, and they covered trending topics in type 1 from new oral meds to groundbreaking glucagon spray.
read more →